Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
OBJECTIVE
The amorphous form of a drug may provide enhanced solubility, dissolution rate, and bioavailability but will also potentially crystallize over time. Miscible polymeric additives provide a means to increase physical stability. Understanding the miscibility of drug-polymer systems is of interest to optimize the formulation of such systems. The purpose of this work was to develop experimental models which allow for more quantitative estimates of the thermodynamics of mixing amorphous drugs with glassy polymers.


METHODS
The thermodynamics of mixing several amorphous drugs with amorphous polymers was estimated by coupling solution theory with experimental data. The entropy of mixing was estimated using Flory-Huggins lattice theory. The enthalpy of mixing and any deviations from the entropy as predicted by Flory-Huggins lattice theory were estimated using two separate experimental techniques; (1) melting point depression of the crystalline drug in the presence of the amorphous polymer was measured using differential scanning calorimetry and (2) determination of the solubility of the drug in 1-ethyl-2-pyrrolidone. The estimated activity coefficient was used to calculate the free energy of mixing of the drugs in the polymers and the corresponding solubility.


RESULTS
Mixtures previously reported as miscible showed various degrees of melting point depression while systems reported as immiscible or partially miscible showed little or no melting point depression. The solubility of several compounds in 1-ethyl-2-pyrrolidone predicts that most drugs have a rather low solubility in poly(vinylpyrrolidone).


CONCLUSIONS
Miscibility of various drugs with polymers can be explored by coupling solution theories with experimental data. These approximations provide insight into the physical stability of drug-polymer mixtures and the thermodynamic driving force for crystallization.
Marsac
Patrick J
PJ
Materials Characterization and Technology Assessment, Merck & Co., Inc., West Point, Pennsylvania 19486, USA.
Li
Tonglei
T
Taylor
Lynne S
LS
D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D006860:Hydrogen Bonding; D008970:Molecular Weight; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D012995:Solubility; D013696:Temperature; D013816:Thermodynamics
D004364:Pharmaceutical Preparations; D011108:Polymers
Int J Pharm. 2002 Jan 14;231(2):131-44
11755266
Drug Dev Ind Pharm. 2002 May;28(5):473-93
12098838
Pharm Res. 2006 Oct;23(10):2306-16
16927182
J Pharm Sci. 1998 Jun;87(6):694-701
9607945
J Pharm Sci. 2000 Oct;89(10):1325-34
10980507
J Pharm Sci. 1998 Dec;87(12):1615-21
10189276
Adv Drug Deliv Rev. 2003 Apr 25;55(4):519-48
12706049
Eur J Pharm Biopharm. 2004 Sep;58(2):445-55
15296966
J Pharm Sci. 1999 Nov;88(11):1182-90
10564068
J Pharm Sci. 1995 Aug;84(8):983-6
7500284
Pharm Res. 2002 Apr;19(4):477-83
12033383
Ophthalmologica. 2001 May-Jun;215(3):143-55
11340382
Int Ophthalmol. 1994;18(1):1-4
7960409
Trans Ophthalmol Soc U K. 1976 Jul;96(2):319-21
1070885
Pharmacol Res. 2008 Mar;57(3):171-80
18339557
Invest Ophthalmol. 1970 Apr;9(4):250-5
5435768
J Cardiovasc Pharmacol. 2008 Feb;51(2):118-25
18287878
J Pharm Sci. 2007 Nov;96(11):2829-37
17979210
Expert Opin Drug Deliv. 2007 Jul;4(4):403-16
17683253
J Pharm Sci. 2006 Dec;95(12):2692-705
16892209
Pharm Res. 2003 Jul;20(7):1047-54
12880291
J Pharm Sci. 1999 Oct;88(10):1058-66
10514356
Crit Rev Ther Drug Carrier Syst. 1984;1(1):39-90
6400195
Eur J Pharm Sci. 2001 Jan;12(3):261-9
11113645
Nanomedicine (Lond). 2007 Aug;2(4):483-509
17716133
Drugs. 1990 Dec;40(6):880-902
2127741
Optom Vis Sci. 1993 Dec;70(12):1012-8
8115123
Drug Dev Ind Pharm. 2002 Aug;28(7):795-807
12236065
Curr Eye Res. 2005 Dec;30(12):1071-80
16354620
Vestn Oftalmol. 1986 May-Jun;102(3):14-7
3727241
J Pharm Sci. 2004 Mar;93(3):646-53
14762903
Pharm Res. 1994 Aug;11(8):1166-73
7971719
South Med J. 2008 Feb;101(2):174-8
18364620
Cardiology. 1991;79 Suppl 2:5-13
1760830
Tissue Eng. 2007 Oct;13(10):2369-85
17658993
Crit Rev Ther Drug Carrier Syst. 2003;20(2-3):215-47
14584524
J Pharm Sci. 2001 Dec;90(12):1991-2004
11745758
Pharm Acta Helv. 1986;61(3):69-88
3520598
Pharm Res. 1997 Dec;14(12):1691-8
9453055
J Biomed Mater Res. 1983 Jan;17(1):109-28
6826569
Pharm Res. 2000 Apr;17(4):397-404
10870982
Pharm Res. 2003 Sep;20(9):1417-22
14567636
Pharm Res. 2006 Oct;23(10):2417-26
16933098